David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
CALL
Halliburton
HAL
$29.4B
| $45.2M | 0.06% |
1,543,300
+663,200
| +75% | +$20M |
|
402
PUT
JD.com
JD
$39.7B
| $45.2M | 0.06% |
1,497,900
-3,740,500
| -71% | -$95.1M |
|
|
SMAR
403
DELISTED
Smartsheet Inc.
SMAR
| $45.1M | 0.06% |
+1,106,288
| New | +$38.2M |
|
404
Omeros
OMER
$1.39B
| $44.9M | 0.06% |
2,585,438
+673,194
| +35% | +$9.71M |
|
|
DLPH
405
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $44.7M | 0.06% |
2,322,437
+743,192
| +47% | +$13.7M |
|
406
PUT
FedEx
FDX
$76.9B
| $44.7M | 0.06% |
246,300
+122,200
| +98% | +$21.6M |
|
407
Pentair
PNR
$10.3B
| $44.6M | 0.06% |
1,001,483
+819,585
| +451% | +$34.1M |
|
408
InterDigital
IDCC
$8.84B
| $43.9M | 0.06% |
666,062
+147,832
| +29% | +$10.3M |
|
409
LKQ Corp
LKQ
$6.52B
| $43.9M | 0.06% |
1,547,897
-49,625
| -3% | -$1.34M |
|
410
Equity Lifestyle Properties
ELS
$12.7B
| $43.8M | 0.06% |
766,924
-240,160
| -24% | -$12.8M |
|
411
Ametek
AME
$54.9B
| $43.7M | 0.06% |
527,257
-35,833
| -6% | -$2.72M |
|
412
PUT
Coca-Cola
KO
$392B
| $43.7M | 0.06% |
932,000
+667,900
| +253% | +$31.2M |
|
413
PUT
JPMorgan Chase
JPM
$935B
| $43.6M | 0.06% |
430,300
-620,200
| -59% | -$63.9M |
|
|
BERY
414
DELISTED
Berry Global Group, Inc.
BERY
| $43.2M | 0.06% |
872,970
+189,638
| +28% | +$8.99M |
|
415
Northrop Grumman
NOC
$78.3B
| $43.1M | 0.06% |
159,806
+133,891
| +517% | +$36.5M |
|
|
NBIS
416
Nebius Group N.V.
NBIS
$59.6B
| $42.7M | 0.06% |
+1,243,235
| New | +$41.2M |
|
417
iShares Core S&P 500 ETF
IVV
$893B
| $42.7M | 0.06% |
150,000
| – | – |
|
|
K
418
DELISTED
Kellanova
K
| $42.5M | 0.06% |
789,371
+708,229
| +873% | +$37.8M |
|
|
MDRX
419
DELISTED
Veradigm Inc. Common Stock
MDRX
| $42.2M | 0.05% |
4,424,985
+1,035,753
| +31% | +$11.4M |
|
420
CALL
Cisco
CSCO
$438B
| $42.2M | 0.05% |
780,800
-262,200
| -25% | -$12.7M |
|
421
Voya Financial
VOYA
$8.86B
| $42.1M | 0.05% |
842,276
-189,545
| -18% | -$8.99M |
|
|
TVTY
422
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $42.1M | 0.05% |
2,396,146
+792,315
| +49% | +$16.9M |
|
|
423
JD.com
JD
$39.7B
| $42M | 0.05% |
1,394,478
-1,890,892
| -58% | -$48.1M |
|
424
Nasdaq
NDAQ
$54.9B
| $41.9M | 0.05% |
1,437,621
-1,939,887
| -57% | -$55.3M |
|
425
Toll Brothers
TOL
$13.7B
| $41.9M | 0.05% |
1,157,584
+349,831
| +43% | +$12.6M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.